Cosmin C. Florescu

Cosmin Florescu practices at Riverside Medical Center in Riverside, California, part of Kaiser Permanente.

Cosmin Florescu's NPI, 1639601842, was assigned on March 28, 2017. Cosmin Florescu graduated from University of California, Irvine, California College of Medicine in 2016. Cosmin Florescu holds California license A169408.

Cosmin Florescu's primary practice is Riverside Medical Center, at 10800 Magnolia Avenue, Riverside, CA 92505 in Riverside County. The practice phone is (951) 353-2000.

Cosmin Florescu's primary practice is Riverside Medical Center in Riverside, California, part of Kaiser Permanente. Cosmin Florescu is also affiliated with Eisenhower Health. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Cosmin Florescu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cosmin Florescu practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Cosmin Florescu's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Cosmin Florescu is licensed in California.

CMS data shows 524 Medicare services from Cosmin Florescu across 5 procedure codes in 2024, for 482 Medicare patients. Medicare paid $64,097 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 482 Medicare patients who saw Cosmin Florescu in 2024. The largest group is 75 to 84, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cosmin Florescu's median patient age at 53, with 53% women.

In 2024, Cosmin Florescu wrote 508 Medicare Part D claims for 296 patients. 98% of them were for generic drugs. CMS names the drug for 432 of them, across 14 drugs with 11 or more claims each, at $1,809 in total drug cost. In 2023, CMS named 379 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Cosmin Florescu for performance year 2024, reported as part of a group. Cosmin Florescu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Cosmin Florescu, published from 2015 to 2021. Cosmin Florescu's most frequent co-authors are Jeffrey Mullen, MD, Vivian Nguyen, MBA, MD and Brooke Elizabeth Sanders, MD.

Cosmin Florescu graduated from University of California, Irvine, California College of Medicine in 2016.